北京
分享至
【V观财报｜白云山附属企业广药二期基金拟收购南京医药11.04%股份】白云山公告，公司附属企业广药二期基金与AHAPL签署了《股份转让合同》，AHAPL拟将所持南京医药144557431股非限售股份转让给广药二期基金，占目标公司股份总数的11.04%，转让价款为7.49亿元。(中新经纬APP)
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
